Anika to Showcase Regenerative Medicine & Orthobiologics Portfolio at the 12th Biennial International Society of Arthroscopy,...
May 13 2019 - 7:30AM
Business Wire
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated
orthopedic and regenerative medicines company specializing in
therapeutics based on its proprietary hyaluronic acid ("HA")
technology, today announced plans to showcase its regenerative
medicine and orthobiologics portfolio at the 12th Biennial
International Society of Arthroscopy, Knee Surgery and Orthopaedic
Sports Medicine (ISAKOS) Congress being held in Cancun, Mexico on
May 12 – 16. Anika will be a gold sponsor of the event, which will
feature a lecture session focused on HYALOFAST and CINGAL. Anika
will also be exhibiting its injectable, HA-based, surgical bone
repair therapy as well as CINGAL and HYALOFAST at booth #221. The
Anika booth will also feature hands-on demonstrations of HYALOFAST
procedures using the HYALOFAST arthroscopic virtual surgery
simulator.
“We’re excited to be a gold sponsor of this year’s ISAKOS
Congress and look forward to showcasing our innovative orthopedic
and regenerative portfolio,” said Joseph Darling, President and
Chief Executive Officer of Anika Therapeutics. “Orthopedic sports
medicine and sports-related injuries are a key focus for us given
our extensive treatment portfolio that spans the continuum of
orthopedic care. This congress represents an important opportunity
for Anika to continue to develop relationships with and gain
clinical insights from orthopedic medicine thought-leaders who will
be critical to the successful launch of our bone repair therapy
later this year.”
The biennial ISAKOS Congress focuses on showcasing a variety of
new preventative, therapeutic and surgical technique information,
allowing attendees to expand their knowledge and enhance their
surgical skills on sports injuries. The congress features surgical
demonstrations, paper presentations, debates, lectures, symposia
and instructional course lectures, as well as lunch time sessions,
e-posters, and technical exhibits by notable global
thought-leaders. ISAKOS boasts more than 3,000 members from over 90
countries around the world.
Below are the Anika-sponsored activities being held at the 2019
ISAKOS Congress:
Lunch Time Session: HYALOFAST: One-Step Cartilage
Regeneration, and CINGAL: Combination Therapy for OA
PainMonday, May 13, 201912:15 – 12:45pmCancun International
Convention Center – Cozumel 3+4Topics/Speakers:
- HYALOFAST: One-Step Cartilage
RegenerationDr. Alberto Gobbi, OASI Bioresearch Foundation, Milano
– Italy
- CINGAL: Combination Therapy for OA
PainDr. Stephen J. French, M.D., FRCS(C), Sports Med CANADA
Anika Exhibit Booth #221
- Featuring the HA-based surgical bone
repair therapy, CINGAL, and HYALOFAST
- HYALOFAST arthroscopic virtual
simulator for demonstrations on surgical application
About Anika Therapeutics, Inc.Anika Therapeutics,
Inc. (NASDAQ: ANIK) is a global, integrated orthopedic and
regenerative medicines company based in Bedford,
Massachusetts. Anika is committed to improving the lives of
patients with degenerative orthopedic diseases and traumatic
conditions with clinically meaningful therapies along the continuum
of care, from palliative pain management to regenerative tissue
repair. The Company has over two decades of global expertise
developing, manufacturing, and commercializing more than 20
products based on its proprietary hyaluronic acid (HA)
technology. Anika's orthopedic medicine portfolio
includes ORTHOVISC®, MONOVISC®,
and CINGAL®, which alleviate pain and restore
joint function by replenishing depleted HA,
and HYALOFAST, a solid HA-based scaffold to aid
cartilage repair and regeneration. For more information about
Anika, please visit www.anikatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190513005056/en/
For Investor Inquiries:Anika Therapeutics, Inc.Sylvia Cheung,
781-457-9000Chief Financial Officer
For Media Inquiries:W2O GroupSonal Vasudev, 917-523-1418
sonal@w2ogroup.com
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2024 to May 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From May 2023 to May 2024